PNN/GRNN Ensemble Processor Design for Early Screening of Breast Cancer  by Land, Walker H. et al.
 Procedia Computer Science  12 ( 2012 )  438 – 443 
1877-0509 © 2012 Published by Elsevier B.V. Selection and/or peer-review under responsibility of Missouri University of Science and Technology. 
doi: 10.1016/j.procs.2012.09.101 
Complex Adaptive Systems, Publication 2
Cihan H. Dagli, Editor in Chief
Conference Organized by Missouri University of Science and Technology
2012- Washington D.C.
PNN/GRNN Ensemble Processor Design for Early Screening of Breast Cancer
Walker H. Land, Jr.*a, Xinpei Maa, Erin Barnesa, Xingye Qiaob, John Heinec,
Timothy Mastersd, Jin Woo Parka
a Department of Bioengineering, Binghamton University, Binghamton, NY 13902-6000, USA.
b Department of Mathematical Sciences, Binghamton University, Binghamton, NY 13902-6000, USA.
c Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute,
                        12902 Magnolia Drive, MRC-CANCONT, Tampa, FL 33612, USA.
d TMAIC, Brackney, PA 18812, USA.
Abstract
Breast cancer screening has reference to screening of asymptomatic, generally healthy women for breast cancer, to identify those 
who should receive a follow up check. Early screening can detect non-invasive ductal carcinoma in situ (called "pre breast 
cancer"), which almost never forms a lump and is generally non-detectible, except by mammography. This paper will describe 
the design and preliminary evaluation of this PNN/GRNN ensemble pre-screener, in the context of a possible pre-screening 
protocol, which may, if required, include other data. The results show that using the ensemble technique provides almost a 20% 
AUC increase over the average standalone PNN and almost 10% over the best performing PNN.
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1. Background
Carcinoma of the breast is second only to lung cancer as a tumor-related cause of death in women. It has been 
reported by the National Cancer Institute (NCI) that 211,300 new cases and 39,800 deaths will occur just in the US
[1]. It also has been proposed that mortality from breast cancer could be decreased by up to 25% provided that all 
women in appropriate age groups are regularly screened [2]. Currently, the method of choice for early screening of 
breast cancer is conventional x-ray mammography, due to its general widespread availability, low cost, speed, and 
noninvasiveness. At the same time, while mammography is sensitive to the detection of breast cancer, it has a low 
positive predictive value (PPV), resulting in costly and invasive biopsies that are only 15%-34% likely to reveal 
malignancy at histological examination [3]. LDA has been used for mass classification with features derived from 
the image automatically [3,4]. Temporal change using SVMs was also incorporated into the classification scheme, 
which showed the temporal features contribute to the classification performance [5]. Habas et al. [6] used features 
derived automatically with a Back Propagation Neural Network (BPNN), a General Regression Neural 
Network(GRNN) and an SVM coupled with decision model reliability analysis using a Knowledge-Based 
Computer-Assisted Detection system [KB-CADe]. In the KB-CADe approach, suspicious Regions of Interest (ROI) 
were compared with related catalogued cases [6]. The knowledge base of the KB-CADe system should improve as 
the number of known catalogued samples increases, but comparisons may become computationally inefficient 
owing to stored redundancies and burdensome because of the sheer number of comparisons [7]. Other researchers 
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applied both decision tree learning and case-based reasoning approaches for predicting breast biopsy outcomes from 
BI-RADS [8] comparisons with the NN decision performance show that the methods are about equivalent.
GRNN Ensemble Formulation Summary
The objective is to design an ensemble processor that uses the gate variables to intelligently combine the outputs 
of competing models [11]. In the application section of this paper, we use Probabilistic Neural Networks (PNN) as 
the competing models. A background and history of ensemble processing may be found in [10]. Once the expected 
error of each competing prediction model is estimated, these expected errors are used to compute the weights for 
each model. When an unknown case is processed, the gate variables are used by the General Regression Neural 
Network (GRNN) to decide which competing models are likely to be the best for this particular case. These models 
are weighted more heavily than the likely inferior models. In particular, one has a training set composed of n cases. 
Each case xi (i =1, …, n) consists of p gate variables: xi,j where j =1, …, p. These gate variables determine in some 
way the relative efficacy of the prediction models. The m competing prediction models provide outputs qi,k for the 
case xi where k =1, …, m. The desired output (the target value) is yi.
For the gate variables and model outputs of a trial case x (which is a future case other than the training set), just 
one subscript is used: xj where j =1, …, p, are the values of the observed gate variables, and qk where k=1, …, m,
are the computed outputs of the m competing prediction models for this trial case.
Define D(x,xi) the weighted Euclidean distance between training case xi and the trial case x, using p sigma 
weights for p gate variables. Then the GRNN ensemble’s predicted squared error for model k may be shown to be:
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It is desired that the final prediction for case x is a linear combination of the outputs of the competing models: 
¦
 
 
m
k
kk qwy
1
ˆ                                                                                        (2)
Here wk is the weight for the k-th model. If the models have the (desirable) property that their predictions are 
unbiased, the following condition must be imposed:
                                                                                        (3)
It can be shown that the linear combination of unbiased estimators having minimum mean-squared error uses 
weights proportional to the reciprocal of each estimator’s variance. If the predicted squared error calculated in (1) is 
used in place of the variance, the following formula is derived for the weights:
                                                                         (4)
The GRNN ensemble processor is trained (i.e., the p sigma weights in the distance metric D(x,xi) are 
optimized) in the usual leave-one-out cross validation manner as follows. To evaluate the quality of a sigma vector, 
a case is removed from the training set and the formulas just shown are used first to estimate the competing models’ 
errors, then compute the wk weights, then weight the competing models to get the grand prediction, and finally 
compute the error of this grand prediction (compared with the true value of the omitted case). This procedure is 
repeated for each training case. The sigma vector providing minimum root mean square (RMS) error is found.
3. Differential Evolution
Price and Storn [9] reported on a variation of genetic optimization called differential evolution. This variation is 
much more appropriate than traditional genetic methods when optimizing a multivariate function. It is especially 
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valuable when the scaling in the different dimensions are not commensurate, a situation commonly found in both 
PNN and GRNN training using poorly prescaled or highly correlated variables. Consequently, differential evolution
was used to train the GRNN ensemble processor.
Differential evolution [9] is similar to traditional genetic optimization in that it starts with a collection of 
parameter sets that will be called the source population. The individuals comprising this population are combined
with each other via crossover and subjected to mutation to produce the members of the destination population. The 
members of the destination population, taken as a group, would generally be expected to be superior to the members 
of the source population. By repeating this process enough times, the best member of the final population should be 
close to the global optimum.
Several important differences exist between traditional genetic optimization and differential evolution, where 
the most important difference is in the nature of the mutation. In traditional genetic optimization, mutation takes the 
form of a random perturbation of a fixed type, such as flipping bits in a binary representation of a parameter set, or 
adding random numbers to specific individual parameters. This approach, however, fails to account for the fact that 
what might be a small perturbation for one parameter might be gigantic for another. Also, random bit flipping can be 
extremely destructive. On the other hand, differential evolution avoids these problems by using the source 
population itself to determine the nature and degree of mutation, by randomly selecting a pair of individuals and 
computing the difference between their parameter vectors. This difference vector is multiplied by a fixed constant 
(around 0.5 or so) and added to the individual being mutated. When optimization begins, the average difference will 
be about the same for all variables being optimized. But as generations pass, the difference will tend to adapt to the 
natural scaling of the problem. Variables having a large natural scale will be distributed over a larger range in the 
population, so mutations for these variables will also be relatively large. As convergence approaches, those variables 
having a narrow and well-defined range around the minimum will have small variation among the population 
members, resulting in their mutations being relatively small. This automatic adaptation significantly improves 
behavior of the algorithm as convergence nears. (Note: Another way to address this problem is to normalize the 
feature covariate set to [0,1] or [-1,1], etc.)
Another important difference is that differential evolution does not involve selection of parents based on fitness. 
Instead, fitness determines which children are kept. In particular, one parent, called the primary parent is selected 
deterministically: each individual in the source population is chosen as a primary parent exactly once. 
Fig.1 Differential Evolution Overview
The other parent, called the secondary parent, is randomly chosen. Two other individuals which make up the 
differential pair are also selected randomly. These two are subtracted and their difference is multiplied by a small 
fixed constant. This scaled difference vector is added to the secondary parent to induce mutation. Ordinary crossover 
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is applied to the primary parent and the mutated secondary parent. The resulting child's fitness is compared to that of 
the primary parent. The winner becomes a new member of the destination population. This entire process is 
illustrated in Figure 1 above.
2. Data Base
The data set consisted of ~200 samples, approximately equally divided between cases and controls. Patient 
Information Data, which included retrospective non-randomized information from the Patient Breast Questionnaire, 
Diagnostic Exams, Pathology data, Magnetic Resonance (MR) breast examinations with the de-identified per 
HIPAA regulations (the Health Insurance Portability and Accountability Act of 1996) MR images and the truth-files 
generated by the radiologist. Two hundred patient cases were collected retrospectively (from 01/01/2005 to 
06/01/06), 100 of which were negative (benign) and 100 were positive (malignant). All cancer-positive cases were 
pathology verified. The patient population represents a subset of those patients encountered in diagnostic 
mammography that are undergoing diagnostic Magnetic Resonance Mammography (MRM). The data is 
retrospective and therefore was acquired with no specific imaging protocol. This collection of MRM subjects are
patients who (1) have a known diagnosis of cancer (to determine extent of disease, evaluate for synchronous 
lesions), (2) have equivocal mammogram (suspicious mammogram finding but not clearly localized) or (3) require 
follow-up after therapy (for example, dense breasts in an XRT/ lumpectomy patient). The collection also consists of 
patients that were scanned prior to their surgeries (known cancer positive patients). The cases that have an equivocal 
mammogram are usually benign and are followed by repeat MRM, ultrasound, or x-ray mammogram. If an 
equivocal finding looks suspicious it is biopsied. The patient data are non-image features, which are: (1) patient age, 
(2) race/ethnicity, (3) weight, (4) age of menarche, (5) duration of menstruation, (6) age of menopause (7) number of 
full term deliveries (8) duration of hormone replacement therapy (9) family history of breast cancer (yes or no), and 
(10) cigarette smoking. The database was pared-down by discarding subjects for a particular trial that had open 
features fields for a given model arrangement (for either feature non-applicable reasons or when the feature was not-
available).
3. Results
PNNs (Probabilistic Neural Networks) were classifiers that were used as inputs to the GRNN ensemble. The 
PNN/GRNN ensemble refers to the GRNN ensemble with the PNNs as inputs. The PNN/GRNN had an area under 
the receiver operating characteristic (ROC) curve (AUC) value of 83.08%. This outperforms the standalone PNNs
by an average of 19.56% AUC and outperforms the best standalone PNN by 9.06% AUC. This result displays that 
the GRNN ensemble has the potential to improve the performance of the PNN to a level that can be used in clinical 
situations. 
Fig. 4. AUC for each feature
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The figure above illustrates each feature’s AUC value. Each feature corresponds to (1) patient age, (2) 
race/ethnicity, (3) weight, (4) age of menarche, (5) duration of menstruation, (6) age of menopause (7) number of 
full term deliveries (8) duration of hormone replacement therapy (9) family history of breast cancer, and  (10) 
cigarette smoking. 
Features 1 2 3 4 5 6 7 8 9 10
1 1.000 -0.262 0.408 0.413 0.470 0.111 -0.162 0.239 0.297 0.299
2 -0.262 1.000 0.010 0.196 0.149 0.262 0.047 0.096 -0.317 -0.007
3 0.408 0.010 1.000 0.011 0.212 0.567 0.263 0.259 -0.018 -0.003
4 0.413 0.196 0.011 1.000 0.473 0.184 0.081 0.263 0.237 0.466
5 0.470 0.149 0.212 0.473 1.000 0.161 0.185 0.112 0.157 0.522
6 0.111 0.262 0.567 0.184 0.161 1.000 0.238 0.040 -0.070 0.025
7 -0.162 0.047 0.263 0.081 0.185 0.238 1.000 -0.100 0.031 0.133
8 0.239 0.096 0.259 0.263 0.112 0.040 -0.100 1.000 -0.254 -0.126
9 0.297 -0.317 -0.018 0.237 0.157 -0.070 0.031 -0.254 1.000 0.348
10 0.299 -0.007 -0.003 0.466 0.522 0.025 0.133 -0.126 0.348 1.000
Table 1. Correlation Matrix of Features
This table shows the correlation matrix between the results of the PNN. This shows that there is low correlation 
between each PNN output. Using clinical variables separately as inputs to the PNN and combining the outputs of 
PNN using GRNN ensemble seems to be a logical idea since it can make use of the lack of correlation between the 
variables.  
Fig. 5. GRNN Ensemble and PNN ROC Curves. The red curve on the top is from the GRNN Ensemble. 
The ROC curve above shows the comparison between each PNN and the GRNN ensemble. The ensemble makes a 
marked improvement over the input PNNs.
4. Conclusions
The PNN/GRNN ensemble had an AUC value of 83.08%. This outperforms the standalone PNNs by an average 
of 19.56% AUC and outperforms the best standalone PNN by 9.06% AUC. This result displays that the PNN/GRNN 
ensemble has the potential to improve the performance of the PNN to a level that can be used in clinical situations
such as a pre screener for breast cancer. This will reduce the overall cost of diagnosing patients as well as 
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conserving clinician’s time. However, additional testing and evaluation must be conducted to evaluate performance 
against intra and inter observer variability (i.e. demographics, life “style”, additional data sets, etc.). 
A comparative analysis was performed with the same non-image feature data base using the following statistical 
learning theory (SLT) algorithms: (1.) kernalized partial least squares (K-PLS), (2.) auto KPLS, which is an 
automated version of K-PLS (where some parameters are optimized by the process), and (3.) an Evolutionary 
Programming –Support Vector Machine (EP-SVM) hybrid. The best AZ result of 0.77 was obtained, as expected, by 
the Auto K-PLS followed by the “standard” K-PLS result of 0.75. The EP-SVM hybrid provided an AZ of 0.64. 
These results, while also preliminary, are very telling when compared with the GRNN ensemble processor result of 
0.83 and demonstrate that this processor is as least more accurate by 7.8% than some of the more sophisticated SLT 
algorithms in use today, for this data base. Question is: what specific information is the ensemble processor 
extracting that is being “missed” by these more sophisticated SLT algorithms?  
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